Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03802799
Recruitment Status : Recruiting
First Posted : January 14, 2019
Last Update Posted : May 22, 2019
Sponsor:
Information provided by (Responsible Party):
Zynerba Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 30, 2019
Estimated Study Completion Date : September 30, 2020